Simone Zanella

Simone Zanella

Auto-generated profile, based on publicly available information

Simone Zanella

Department of Chemistry, University of Konstanz, 78467 Konstanz, Germany

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 February 2020 in Science
Verified
Journal Article
Closed access
PDF file
FSFabian Schneider
Fabian Schneider
KSKonstantin Samarin
Konstantin Samarin
SZSimone Zanella
Simone Zanella
TGTanja Gaich
Tanja Gaich
Synthesis of Taxol's complicated cousin: Propellane molecules contain three rings that all share a common edge, thereby collectively resembling a propeller. Canataxpropellane, a yew-derived natural product related to the cancer drug Taxol, is unusual in that it has two different propellane motifs in its backbone. Schneider et al. report a chemical synthesis of this intricate compound in under 30 steps. Key features of the route include a Diels-Alder reaction rendered asymmetric by introduction of a chiral silyl auxiliary, followed by a photochemical cycloaddition to establish the cyclobutane core. Science , this issue p. 676

26 May 2017 in Chemistry – A European Journal
Verified
Journal Article
Open access
PDF file
SZSimone Zanella
Simone Zanella
SASimona Angerani
Simona Angerani
APArianna Pina
Arianna Pina
PRPaula López Rivas
Paula López Rivas
CGCLELIA GIANNINI
CLELIA GIANNINI
CGCesare Gennari
Cesare Gennari
Herein we report the first example of an isoDGR–drug conjugate (2), designed to release paclitaxel selectively within cancer cells expressing integrin αVβ3. Conjugate 2 was synthesized by connecting the isoDGR peptidomimetic 5 with paclitaxel via the lysosomally cleavable Val–Ala dipeptide linker. Conjugate 2 displayed a low nanomolar affinity for the purified integrin αVβ3 receptor (IC50=11.0 nm). The tumor targeting ability of conjugate 2 was assessed in vitro in anti‐proliferative assays on two isogenic cancer cell lines characterized by different integrin αVβ3 expression: human glioblastoma U87 (αVβ3+) and U87 β3‐KO (αVβ3−). The isoDGR‐PTX conjugate 2 displayed a remarkable targeting index (TI=9.9), especially when compared to the strictly related RGD‐PTX conjugate 4 (TI=2.4).